INBS
Intelligent Bio·NASDAQ
--
--(--)
--
--(--)
INBS fundamentals
Intelligent Bio (INBS) released its earnings on Aug 15, 2025: revenue was 843.88K (YoY +15.60%), missed estimates; EPS was -3.6 (YoY -103.75%), missed estimates.
Revenue / YoY
843.88K
+15.60%
EPS / YoY
-3.6
-103.75%
Report date
Aug 15, 2025
EPS
Actual | -240 | -552 | -216 | -360 | -192 | -55.2 | -686.4 | -124.8 | -20.7 | -14.3 | 96 | -7 | -5 | -4.4 | -3.6 | |
Forecast | -552 | -648 | -168 | -240 | -264 | -324 | -76.8 | -32.4 | -8.7 | -5.1 | -5.3 | -3.2 | -2.8 | -1.2 | ||
Surprise | 0.00% | 0.00% | 0.00% | +66.67% | -114.29% | +20.00% | +79.09% | -111.85% | -62.50% | +36.11% | -64.37% | +1982.35% | -32.08% | -56.25% | -57.14% | -200.00% |
Revenue
Actual | -- | -- | 177.79K | 192.50K | -- | 311.32K | 356.68K | 457.06K | 796.09K | 764.06K | 823.80K | 730.00K | 872.29K | 607.49K | 728.87K | 843.88K |
Forecast | -- | -- | 300.00K | 0 | 1.60M | 0 | 700.00K | 420.00K | 1.00M | 1.00M | 1.20M | 1.40M | 1.80M | 2.30M | 3.30M | 4.30M |
Surprise | 0.00% | 0.00% | -40.74% | 0.00% | 0.00% | 0.00% | -49.05% | +8.82% | -20.39% | -23.59% | -31.35% | -47.86% | -51.54% | -73.59% | -77.91% | -80.37% |
Earnings Call
You can ask Aime
What is Intelligent Bio's gross profit margin?What were the key takeaways from Intelligent Bio’s earnings call?What is the market's earnings forecast for Intelligent Bio next quarter?What is Intelligent Bio's latest dividend and current dividend yield?What factors drove the changes in Intelligent Bio's revenue and profit?What guidance did Intelligent Bio's management provide for the next earnings period?Did Intelligent Bio beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Intelligent Bio year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
